Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy

Annals of Surgical Oncology

Volumn 8, Issue 10, 2001, Pages 766-770

  Dessureault, Sophie ^a,f   Soong, Seng Jaw ^b,f   Ross, Merrick I ^c,f   Thompson, John F ^d,f   Kirkwood, John M ^e,f   Coit, Daniel G ^a,f   McMasters, Kelly M ^f,g   Balch, Charles M ^f,h   Reintgen, Douglas ^a,f  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF LOUISVILLE   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Lymphatic mapping; Melanoma; Sentinel lymph node; Staging; Survival

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

EID: 18244390527     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-001-0766-1     Document Type: Article

References (22)

1. Prognosis of patients with pathologic stage II cutaneous malignant melanoma
2. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes
3. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients
4. A multifactorial analysis of melanoma. II. Prognostic factors in patients' with stage I (localized) melanoma
5. The role of elective lymph node dissection in melanoma: Rationale, results, and controversies
6. Inefficacy of immediate node dissection in stage I melanoma of the limbs
7. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
8. A prospective randomized study of the efficacy of routine elective lymph-adenectomy in management of malignant melanoma. Preliminary results
9. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study
10. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
11. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)
12. Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma
13. Anatomy and biopsy of sentinel lymph nodes
14. Technical details of intra-operative lymphatic mapping for early stage melanoma
15. Intraoperative identification of sentinel lymph node in patients with malignant melanoma
16. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma
17. Pathologic examination of the sentinel lymph node
18. Radioguided surgery for the ultrastaging of the patient with melanoma
19. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymph-adenectomy for early-stage melanoma: A multicenter trial
20. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial
21. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma
22. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684